$CCXI News Article - ChemoCentryx Reports Pharmaco
Post# of 85277
(Total Views: 155)
Posted On: 04/13/2022 3:10:54 PM
$CCXI News Article - ChemoCentryx Reports Pharmacokinetic and Pharmacodynamic Results from Ongoing Phase I Trial of Orally Administered PD-L1 Inhibitor, CCX559, at American Association for Cancer Research (AACR) Annual Meeting 2022 https://marketwirenews.com/news-releases/chem...49697.html
(0)
(0)
My Twitter: WhyteStocks
Scroll down for more posts ▼